Drug Delivery Systems
More Bioavailability, Less Side-Effects
NanoHarmonics is working with several biotech companies to develop, do clinical trials, secure regulatory compliance approvals, and commercialize improved drugs. We aim to reformulate and repurpose existing medicines for oncology, for infectious diseases as well as develop new ones in partnership with other pharmaceutical companies.
Our Quantum Dot bio-diagnostics technology will help accelerate the drug development process by bringing the capability to monitor the trends of target biomarkers affected by active pharmaceutical ingredients and their combination.
"That our generation has the capability to work with the smallest kernels of our existence is truly astounding. To use atoms to measure biomarkers…then to use bits to organize and secure the data into useful information…then use those information to develop drug delivery systems that will benefit mankind. It’s the convergence of technologies based on discoveries surrounding the atom, the bit, and the cell that will drive the next technological revolution in our society."
We have the foundational technology to develop rapid and quantitative diagnostic tests for different biomarkers using Quantum Dots. Our patented Quantum Dot technology makes our diagnostic tests ideal for immunity level detection, infectious disease management, and biomarker monitoring in both personal health and drug delivery technology.
A companion to our Quantum Dot technology is a secured, encrypted data platform. Our platform captures and organizes the data necessary to monitor biomarker trends in personal health, expedite drug development through biomarker tracking, and anonymize positive or negative results in infectious disease management.
We are partnering with several pharmaceutical companies to develop novel drug delivery systems. Through our Quantum Dot diagnostic technology and our data collection platform we can expedite new drugs with higher bioavailability of active pharmaceutical ingredients (API) and substantially reduced toxicity and side effects.